US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 4.490
  • -0.360-7.42%
Close Dec 3 16:00 ET
  • 4.490
  • 0.0000.00%
Post 16:02 ET
239.63MMarket Cap-4726P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-73.01%1.05M
-82.97%536K
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
Operating revenue
-73.01%1.05M
-82.97%536K
-91.68%566K
55.52%21.05M
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.8M
33.47%13.54M
8.44%3.1M
Cost of revenue
Gross profit
Operating expense
17.59%33.67M
24.83%34.65M
8.10%31.94M
42.83%114.51M
31.38%28.57M
43.60%28.64M
43.81%27.76M
54.01%29.55M
36.39%80.17M
27.49%21.74M
Selling and administrative expenses
25.70%7.41M
19.02%7.77M
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
-General and administrative expense
25.70%7.41M
19.02%7.77M
-8.82%7.08M
29.49%26.35M
0.36%6.16M
20.04%5.89M
35.84%6.53M
72.83%7.77M
47.18%20.35M
38.04%6.14M
Research and development costs
15.48%26.26M
26.62%26.88M
14.13%24.86M
47.37%88.15M
43.59%22.41M
51.29%22.74M
46.45%21.23M
48.26%21.78M
33.07%59.82M
23.76%15.6M
Operating profit
-31.82%-32.62M
-38.62%-34.11M
-37.95%-31.37M
-40.25%-93.46M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-37.00%-66.64M
-31.31%-18.65M
Net non-operating interest income expense
56.20%2.74M
334.16%2.45M
583.89%1.23M
921.69%4.24M
2,456.76%1.74M
425.83%1.75M
279.19%565K
2,471.43%180K
2,493.75%415K
-3,800.00%-74K
Non-operating interest income
35.13%3.69M
121.97%3.41M
92.78%2.19M
402.77%8M
188.12%2.6M
411.80%2.73M
929.53%1.53M
16,128.57%1.14M
9,843.75%1.59M
44,950.00%901K
Non-operating interest expense
-2.44%958K
-1.75%952K
0.31%959K
219.64%3.76M
-12.62%852K
388.56%982K
--969K
--956K
--1.18M
--975K
Other net income (expense)
Income before tax
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Income tax
Net income
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Net income continuous Operations
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Minority interest income
Net income attributable to the parent company
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Basic earnings per share
-4.17%-0.25
45.10%-0.28
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
Diluted earnings per share
-4.17%-0.25
45.10%-0.28
65.59%-0.32
50.55%-1.36
85.90%-0.11
64.18%-0.24
19.05%-0.51
-38.81%-0.93
34.05%-2.75
-31.32%-0.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -73.01%1.05M-82.97%536K-91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M
Operating revenue -73.01%1.05M-82.97%536K-91.68%566K55.52%21.05M132.99%7.21M15.58%3.89M-22.39%3.15M125.19%6.8M33.47%13.54M8.44%3.1M
Cost of revenue
Gross profit
Operating expense 17.59%33.67M24.83%34.65M8.10%31.94M42.83%114.51M31.38%28.57M43.60%28.64M43.81%27.76M54.01%29.55M36.39%80.17M27.49%21.74M
Selling and administrative expenses 25.70%7.41M19.02%7.77M-8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M
-General and administrative expense 25.70%7.41M19.02%7.77M-8.82%7.08M29.49%26.35M0.36%6.16M20.04%5.89M35.84%6.53M72.83%7.77M47.18%20.35M38.04%6.14M
Research and development costs 15.48%26.26M26.62%26.88M14.13%24.86M47.37%88.15M43.59%22.41M51.29%22.74M46.45%21.23M48.26%21.78M33.07%59.82M23.76%15.6M
Operating profit -31.82%-32.62M-38.62%-34.11M-37.95%-31.37M-40.25%-93.46M-14.52%-21.36M-49.28%-24.75M-61.42%-24.61M-40.71%-22.74M-37.00%-66.64M-31.31%-18.65M
Net non-operating interest income expense 56.20%2.74M334.16%2.45M583.89%1.23M921.69%4.24M2,456.76%1.74M425.83%1.75M279.19%565K2,471.43%180K2,493.75%415K-3,800.00%-74K
Non-operating interest income 35.13%3.69M121.97%3.41M92.78%2.19M402.77%8M188.12%2.6M411.80%2.73M929.53%1.53M16,128.57%1.14M9,843.75%1.59M44,950.00%901K
Non-operating interest expense -2.44%958K-1.75%952K0.31%959K219.64%3.76M-12.62%852K388.56%982K--969K--956K--1.18M--975K
Other net income (expense)
Income before tax -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Income tax
Net income -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Net income continuous Operations -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Minority interest income
Net income attributable to the parent company -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Basic earnings per share -4.17%-0.2545.10%-0.2865.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.78
Diluted earnings per share -4.17%-0.2545.10%-0.2865.59%-0.3250.55%-1.3685.90%-0.1164.18%-0.2419.05%-0.51-38.81%-0.9334.05%-2.75-31.32%-0.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+3.51%
Coinbase
COIN
+2.30%
Amazon
AMZN
+1.30%
Apple
AAPL
+1.28%
Oracle
ORCL
+0.82%

Unlock the Full List